Anbio Biotechnology (NASDAQ:NNNN) Sees Large Volume Increase – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNN) saw an uptick in trading volume on Monday . Approximately 146,631 shares changed hands during trading, an increase of 111% from the previous session’s volume of 69,418 shares.The stock last traded at $6.2910 and had previously closed at $6.34.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, July 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

Anbio Biotechnology Stock Performance

The business has a 50-day moving average of $8.74 and a two-hundred day moving average of $18.45.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.